<p>Fort Lee, NJ, Sept. 01, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company fo
The US Dollar fell as the S&P 500 and Dow Jones climbed despite rising coronavirus cases in the US. With earnings season in full swing, all eyes turn this week to Microsoft after dismal figure
Leave a Comment